Olivier Goulet1, Francisca Joly, Odile Corriol, Virginie Colomb-Jung. 1. Department of Pediatric Gastroenterology, Hepatology and Nutrition, Intestinal Failure Rehabilitation Center, Hospital Necker-Enfants Malades, University of Paris-Descartes, 75743 Paris Cedex 15, Paris, France. olivier.goulet@nck.aphp.fr
Abstract
PURPOSE OF REVIEW: To point new insights in the cholestasis that is a complication of both intestinal failure and parenteral nutrition. View on liver disease has recently evolved with the onset of fish oil-based intravenous lipid emulsions (ILE). RECENT FINDINGS: Focused on the role of ILE in causing liver disease. Reversal of cholestasis was recently achieved in infants with short bowel syndrome, by replacing the 'reference' soybean oil-based ILE by fish oil-based ILE. SUMMARY: It is likely that this reversal involves several factors such as the change in n-6: n-3 ratio, the reduction in phytosterol load, the increased provision of alpha-tocopherol as antioxidant agent. Alternative issue might be based on the use of a new generation of ILE aiming to provide n-3 and to reduce n-6 fatty acids load while enhancing alpha-tocopherol intake. New data are based on the use of an ILE containing a balanced proportion of four types of oil as a physical mixture of 30% soybean oil, 30% medium-chain triglycerides, 25% olive oil and 15% fish oil with amounts of alpha-tocopherol calculated according to the number of double bonds. This new emulsion was reported to be beneficial in reversing or preventing liver disease.
PURPOSE OF REVIEW: To point new insights in the cholestasis that is a complication of both intestinal failure and parenteral nutrition. View on liver disease has recently evolved with the onset of fish oil-based intravenous lipid emulsions (ILE). RECENT FINDINGS: Focused on the role of ILE in causing liver disease. Reversal of cholestasis was recently achieved in infants with short bowel syndrome, by replacing the 'reference' soybeanoil-based ILE by fish oil-based ILE. SUMMARY: It is likely that this reversal involves several factors such as the change in n-6: n-3 ratio, the reduction in phytosterol load, the increased provision of alpha-tocopherol as antioxidant agent. Alternative issue might be based on the use of a new generation of ILE aiming to provide n-3 and to reduce n-6 fatty acids load while enhancing alpha-tocopherol intake. New data are based on the use of an ILE containing a balanced proportion of four types of oil as a physical mixture of 30% soybeanoil, 30% medium-chain triglycerides, 25% oliveoil and 15% fish oil with amounts of alpha-tocopherol calculated according to the number of double bonds. This new emulsion was reported to be beneficial in reversing or preventing liver disease.
Authors: Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff Journal: Clin Nutr Date: 2019-01-16 Impact factor: 7.324
Authors: Igor Sukhotnik; Hila Razon; Yulia Pollak; Lili Hayari; Jacob Bejar; Jorge G Mogilner; Karl G Sylvester Journal: Pediatr Surg Int Date: 2012-02 Impact factor: 1.827
Authors: Christina Belza; John C Wales; Glenda Courtney-Martin; Nicole de Silva; Yaron Avitzur; Paul W Wales Journal: JPEN J Parenter Enteral Nutr Date: 2019-08-25 Impact factor: 4.016
Authors: F Adaba; M Uppara; F Iqbal; S Mallappa; C J Vaizey; S M Gabe; J Warusavitarne; J M D Nightingale Journal: Eur J Clin Nutr Date: 2015-09-09 Impact factor: 4.016
Authors: Zev H Davidovics; Beth A Carter; Ruth Ann Luna; Emily B Hollister; Robert J Shulman; James Versalovic Journal: JPEN J Parenter Enteral Nutr Date: 2015-06-09 Impact factor: 4.016